Research progress on the mechanisms of omental metastasis in gastric cancer

doi:10.16352/j.issn.1001-6325.2026.02.0282

Abstract

Abstract: Omental metastasis is recognized as one of the most common pathways of metastasis in advanced gastric cancer and is also a key factor contributing to poor prognosis in patients with advanced gastric cancer. Research has extensively focused on various aspects concerning the mechanisms of gastric cancer omental metastasis, including the tumor microenvironment, genes, adhesion molecules, exosomes, calreticulin, and complement. These factors act on the basis of the implantation of free cancer cells in the abdominal cavity. This article reviews recent advances in understanding the mechanisms of gastric cancer omental metastasis and discusses their potential research and clinical implications.

Key words: gastric cancer, omental metastasis, mechanism research

CLC Number:

R735.2

LONG Fangwen, ZHENG Xia, QIAN Jun, ZHANG Yifen. Research progress on the mechanisms of omental metastasis in gastric cancer[J]. Basic & Clinical Medicine, 2026, 46(2): 282-287.

References

[1]Macrì A, Morabito F. The use of intraperitoneal chemotherapy for gastric malignancies[J]. Expert Rev Anticancer Ther, 2019,19:879-888.
[2]Gerber AS,Rybalko YV,Bigelow EC, et al.Preferential attachment of peritoneal tumor metastases to omental immune aggregates and possible role of a unique vascular microenvironment in metastatic survival and growth[J].Am J Pathol,2006,169:1739-1752.
[3]Liu X,Miao Z,Zhao T, et al.Milky spot macrophages remodeled by gastric cancer cells promote peritoneal mesothelial cell injury[J].Biochem Biophys Res Commun,2013,439:378-383.
[4]Nieman KM, Kenny HA, Penicka CV,et al.Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth[J].Nat Med, 2011, 17:1498.doi:10.1038/nm.2492.
[5]Clark R,Krishnan V,Schoof M, et al.Milky spots promote ovarian cancer metastatic colonization of peritoneal adipose in experimental models[J].Am J Pathol,2013,183:576-591.
[6]Takahiro S,Yunlong Y,Xiaoting S, et al.Brown-fat-mediated tumour suppression by cold-altered global metabolism[J].Nature,2022,608:421-428.
[7]胡海,陈德,钱世鸥,等.E-选择素在肝细胞癌转移作用中的实验研究[J].中华普通外科学文献,2008,2:104-108.
[8]Qu J,Qu X,Zhao M, et al.Gastric cancer exosomes promote tumour cell proliferation through PI3K/Akt and MAPK/ERK activation[J].Dig Liver Dis,2009,41:875-880.
[9]Daren L,Chao L,Bogusz T, et al.CD97 promotion of gastric carcinoma lymphatic metastasis is exosome dependent[J].Gastric Cancer,2016,19:754-766.
[10]Guang D,Jinglei Q,Ye Z, et al.Gastric cancer-derived exosomes promote peritoneal metastasis by destroying the mesothelial barrier[J].FEBS Lett,2017,591:2167-2179.
[11]Jitka F,Radek S,Guido K, et al.Calreticulin and cancer.[J].Cell Res,2020,31:5-16.
[12]Luo Y, Ma J, Lu W.The significance of mitochondrial dysfunction in cancer[J].Int J Mol Sci, 2020, 21:5598.doi:10.3390/ijms21165598.
[13]Wang SF, Chen MS, Chou YC,et al.Mitochondrial dysfunction enhances cisplatin resistance in human gastric cancer cells via the ROS-activated GCN2-eIF2α-ATF4-xCT pathway[J].Oncotarget, 2016, 7:74132-74151.doi:10.18632/oncotarget.12356.
[14]Han A, Li C, Zahed T,et al.Calreticulin is a critical cell survival factor in malignant neoplasms[J].PLoS Biol, 2019,17:e3000402. doi:10.1371/journal.pbio.3000402.
[15]Ruben B,Pratyaksha W,Marius M, et al.CXCL9:SPP1 macrophage polarity identifies a network of cellular programs that control human cancers[J].Science,2023,381:515-524.
[16]Li Y,Zheng Y,Huang J, et al.CAF-macrophage crosstalk in tumour microenvironments governs the response to immune checkpoint blockade in gastric cancer peritoneal metastases[J].Gut,2025,74:350-363.
[17]Lawal B, Tseng S H, Olugbodi J O,et al.Pan-cancer analysis of immune complement signature C3/C5/C3AR1/C5AR1 in association with tumor immune evasion and therapy resistance[J].Cancers, 2021,13:4124.doi:10.3390/CANCERS13164124.
[18]Pierre-Emmanuel B,Guillaume P,Vahan K, et al.Cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy for gastric cancer with peritoneal metastases (CYTO-CHIP study): a propensity score analysis[J].J Clin Oncol,2019,37:2028-2040.
[19]康欢荣,蒋建,杜楠.腔内热灌注联合贝伐珠单抗治疗恶性胸腹腔积液的疗效观察[J].临床肿瘤学杂志,2014,19:350-353.
[20]陈磊,丁德权,何昌霞.重组人血管内皮抑素联合多西紫杉醇治疗胃癌恶性腹腔积液的疗效[J].中国肿瘤临床与康复,2015,22:1215-1217.